Money hunt
4 minutes ago
A New Treatment Paradigm: Next-Generation Obesity Treatment
Our clinical-stage lead candidate, EL-22, activates the body’s own immune system to inhibit myostatin, a negative regulator of muscle growth.
Data suggests that blocking myostatin causes muscle cell growth and increase